Featured news | Nanologica

Nanologica’s Interim Report Jan – Jun 2022

19 August, 2022

FINANCIAL SUMMARY Net sales for the quarter amounted to TSEK 210 (4,497) and for the half-year to TSEK 479 (10,119) The operating result for the quarter amounted to TSEK -12,397 (-8,094) and for the half-year to TSEK -27,989 (-14,862) Result after tax for the quarter amounted to TSEK -13,473 (-9,216) and for the half-year to TSEK -29,388 (-17,061) Earnings per share before and after dilution were SEK -0.48 (-0.33) for the quarter and SEK -1.04

Nanologica Takes Order from Insulin Manufacturer for Production

11 August, 2022

Nanologica AB (publ) has taken an order for the company’s silica for preparative chromatography for evaluation in production scale, from one of the world’s largest manufacturers of insulin. If the products meet the customer’s expectations, Nanologica expects commercial deliveries within a year. Nanologica has been working with customers within preparative chromatography since 2016 and several customers have successfully evaluated the company’s silica for preparative chromatography, NLAB Saga®, in various stages. Nanologica has been collaborating with

Nanologica Expands Management Team for Increased Focus on Chromatography

10 August, 2022

Nanologica AB (publ) has expanded its management team with Katarina Alenäs, SVP Chromatography, as part of intensifying the company’s efforts within preparative chromatography. Katarina Alenäs took up her position as SVP Chromatograhy at Nanologica in the beginning of March, and most recently came from a role as Business Team Manager Sweden and Finland, Country General Manager Sweden and chairman of the board of Agilent Technologies Sweden AB. Katarina has a solid background and a strong

5 quick questions with Chunfang Zhou

9 August, 2022

Chunfang Zhou, Sales Manager China, Nanologica AB Who are you? My name is Chunfang Zhou and I am Nanologica’s Sales Manager in China. I am originally from China where I studied Chemical Engineering and did my PhD in Physical Chemistry. I also have a Post Doc from the University of Aveiro in Portugal. I have worked with nanoporous silica for more than 20 years, both within drug delivery and in chromatography. What is your current

5 Quick Questions with PK Dutta

30 June, 2022

P.K. DUTTA, Ph.D., SVP Sales Nanologica AB Who are you? I am a Molecular Biologist by training. I have spent most of my career dealing with large scale silica based industrial purification of peptides and small molecules. Before joining Nanologica, I held leadership and strategic roles for global silica brands like Waters, Kromasil and YMC. I am very honored to be part of the Nanologica Business Development Team, establishing a more significant presence in the

Analytica in Munich

14 June, 2022

Next week from June 21 to 24, Nanologica will be at Analytica in Munich! Analytica is the leading industry event for analytics, laboratory technology and biotechnology. With 1,200 exhibitors, 36,000 visitors and 55,000 square meters of exhibition space, Analytica is the largest trade fair for analysis, laboratory technology and biotechnology in the world. As the industry’s definitive forum, Analytica gives visitors a comprehensive market overview and information about the latest developments in laboratory technology, analysis

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.